The first genetically engineered (GE) food crop (tomato) was introduced in 1995, followed by the successful development and commercial release of maize, soybeans, cotton, canola, potatoes, papaya, alfalfa, squash, and sugar beets with specific new genetic traits. Even though the safety of every new GE crop has been evaluated by various regulatory authorities throughout the world prior to its commercial release, the ongoing public debate about the safety of food and feed derived from GE plants has not abated. Such debates often overshadow an important fact that all crops used as human food or animal feed include varieties that have been developed through conventional breeding and selection over hundreds or thousands of years, or through intentional but random mutagenesis. Developing food crops through such breeding practices result in large-scale genomic changes in the resulting crops, and these genomic changes do not undergo molecular characterization. In contrast, new GE crops are developed using well-characterized DNA fragments and the resulting crops are tested and evaluated with much greater scrutiny. This document reviews the safety data and information of GE crops and foods obtained from them.
processes. Collectively, the work conducted to date has identified no evidence of adverse health or nutritional effects from commercially available GE crops or from the foods obtained from them.
In common parlance, GE crops are most often referred to as genetically modified (GM) crops or GM organisms, but the phrase "genetically modified" is not an accurate description because all crops are GM through natural mutations and natural hybridization and genome duplication, followed by selective breeding to improve crop quality and quantity. Such genetic modifications are random, not targeted, and usually involve large-scale changes in the plant genome that have not been characterized. In contrast, genetic engineering involves precise and targeted introduction of a piece of DNA that has been thoroughly characterized and the resulting GE crops characterized using scientifically validated methods (Ladics et al., 2015) .
The GE crops developed so far were designed to produce specific agronomic phenotypes such as resistance to insect pests or plant viruses, provide hybrid seed production, or provide tolerance to specific herbicides for better weed control (ILSI Research Foundation, 2017) . Some GE crops (eg, soybean) also have been developed to specifically enhance nutrient content, such as the introduction of high levels of oleic fatty acid (Wilson, 2012) .
GENETIC ENGINEERING TECHNIQUES
The first generation of GE crops was developed by introducing protein-coding genes from other species (transgenes). Some were from bacteria that were used as organic pesticides (eg, Bacillus thuringiensis [Bt]) or from a plant virus (eg, potato leafroll virus, papaya ringspot virus). Most successful GE crops have been developed for large-scale commodity crops (eg, maize, potato, soybean). The same methods are being used today to generate insect-resistant crops specifically grown in small markets (eg, bacterial-resistant bananas and citrus greening-resistant fruit trees). Additional GE crops were developed by introducing noncoding segments or partial coding segments of DNA to suppress the expression of specific viral or endogenous genes (some viral resistant GE crops and polyphenol oxidase suppressing apples) that act through RNA inhibition. These are sometimes referred to as the "second generation GE food crops".
Recent development of advanced genome editing tools, including zinc finger nucleases, TALENs, or CRISPR-Cas9, are providing opportunities to develop what can be described as the next generation of GE crops by introduction of foreign DNA with methods that differ from those described above. However, these technologies also can be used to cut or make site-specific mutations in endogenous genes (ie, genome editing) without introducing any new DNA into the genome of the plant or by silencing endogenous genes. In fact, because genome editing does not introduce foreign DNA into the crop, regulatory agencies are still determining whether plants developed with this technology and the foods from them would be considered GE or not. In the cases of certain apples, potatoes, and mushrooms developed with these methods, some regulatory agencies have concluded that safety testing akin to that conducted with foods from GE crops was not necessary (US FDA, March 12, 2015, and March 16, 2015; Waltz, 2016) . Furthermore, the genome-edited crops are not yet widely commercialized (Wolt et al., 2016) , and extensive safety data for such crops are not yet available. Thus, this document focuses on the safety of foods obtained from or produced by the first and second generation GE food crops.
For current GE crops, the genetic material was introduced into the embryonic or undifferentiated tissue of the recipient (host) plant using either an engineered natural plant pest, Agrobacterium tumefaciens for introduction of DNA into cells, or physical methods of introduction using biolistic methods with DNA coated on metal beads. Once the DNA is inserted into the plant chromosome, the DNA insert is characterized to define (1) the number of insertion sites (ie, the number of sites in the genome in which the specific DNA insert is integrated) and (2) the copy number (ie, the number of copies of the DNA insert integrated per insertion site in the genome). In crops targeted for the expression of a protein, the introduced DNA insert includes the protein-coding sequence (open reading frame) along with the regulatory sequences (promoter and terminator) required for its expression.
Suppression of expression of specific viral and endogenous proteins has currently been achieved by inserting DNA that produces a complementary strand of RNA specific to viral RNA or endogenous RNA. The segments of interfering RNA can be single-stranded or double-stranded RNA (dsRNA) that activates natural suppression of the RNA by induction of specific dsRNAse or blocking RNA function. The overall process is called RNA interference (RNAi) technology. RNAi is a natural process that combats infection of RNA viruses or controls expression of endogenous gene expression (Eamens et al., 2008; Vaucheret, 2006) . Methods using RNAi are being investigated for controlling diseases and organisms that attack plants and animals, as well as medicinal control of cancers and metabolic disease as can be seen by searching PubMed with "RNAi" and "genetic engineering". The use of RNAi reduces protein expression and does not add any new proteins and thus no proteins requiring specific evaluation.
In some crops, a gene encoding a selectable marker trait (eg, antibiotic resistance markers [ARMs], such as NPTII for kanamycin resistance, or metabolic selection with a limited carbon source using phosphomannose isomerase) also is introduced to permit highly efficient selection of transformed cells and tissues. Some critics of GE have targeted the use of ARMs as causing a risk for their medical use, although there are no cases of harm caused by addition of allowed selectable markers. Recently, some developers are using marker-free transformation processes to avoid incorporation of selectable markers or to remove markers, although each of the methods, such as Cre/ Lox, present similar technical challenges (Vega et al., 2008) .
SUBSTANTIAL EQUIVALENCE AS A CONCEPT FOR EVALUATING THE SAFETY OF GE CROPS: A COMPARISON WITH CLOSELY RELATED NONGE CROP VARIETIES
The general concept of substantial equivalence was first developed by international scientific authorities including the Organisation for Economic Co-operation and Development (OECD), Food and Agriculture Organization of the United Nations (FAO), and World Health Organization (WHO) joint efforts, and the Codex Alimentarius Commission in the early 1990s to evaluate new varieties of crops generated through biotechnology modification methods (Martens, 2000) . It was adopted for GE food crops with the understanding that if any particular GE crop food composition was similar to that of nonGE varieties with a history of safe use for food and feed, except for the intended difference (transgene and products), the GE plant would be considered to be "as safe as" the nonGE variety (Kuiper et al., 2002; Maryanski, 1995; OECD 1993; U.S. FDA, 1992) . In such cases, there would not be a need for additional testing beyond evaluation of the safety of the newly introduced trait.
The composition of diverse crops commonly used in food have characteristic ranges of natural variability of total protein, amino acids, fat (total and individual fatty acids), carbohydrates, minerals, and vitamins due to a combination of genetic diversity within the species and diverse growing conditions. Some crops contain specific "key" nutrients and anti-nutrients (soybean), allergens (soybean), celiac-inducing glutens (cereals), or toxins (potato). Evaluation of substantial equivalence focuses on comparing the most genetically similar varieties (parent or near isoline) as the primary focus, but studies also should include more genetically diverse populations. The focus of these analyses is determining whether the process of making the particular genetically engineered event might have altered concentrations of key components of the host. Importantly, testing the same varieties of inbred crops grown in different environments also results in varied levels of many components. The evaluation is not intended to compare every measurable component, but, rather, components that are relevant for safety and nutrition, and it does not demand absolute equivalence. Many examples of these comparison studies have been published for individual GE crops including corn (Ridley et al., 2002) , soybean (Harrigan et al., 2007) , alfalfa (McCann et al., 2006) , rice (Li et al., 2007; Oberdoerfer et al., 2005) , and other field crops, though references have been limited here to conserve space.
Multilocation field studies are conducted across a range of diverse environment, and compositional endpoint in the GE event are compared to a genetically similar nonGE event and often several commercial reference varieties. Tolerance intervals, which are statistically derived intervals based on compositional data accumulated from a range of commercial varieties of the crop grown in a range of diverse environment, also are used to represent the expected reference ranges (Chen et al., 2015; Hong et al., 2014) . If measurement of any particular component is found to be statistically different from a genetically similar counterpart (eg, parent or near-isogenic line) grown in adjacent field plots, the values should be compared to the expected reference range for the species to determine if the differences are within the natural variation for that crop. If the component is within the range of natural variability for that crop, then it is likely that the statistical difference would be considered not biologically relevant. Identified differences falling outside of expected range should be considered in the context of their relevance to human and livestock health. A benefit of using substantial equivalence to evaluate acceptable ranges of individual components is the flexibility of considering evolution of improvements in the genetic variation in the crop species used in agricultural production or improvements brought about through field practices.
In some cases, feeding studies have been conducted with livestock species to compare the nutritional performance between whole grains or processed feed fractions from GE and nonGE crops. For example, MON810 is a GE maize event that expresses a low level of the Cry1Ab protein from the commonly used bacterial organic pesticide Bt, for resistance to select lepidopteran insect pests. The newly expressed protein is present in low concentrations and would not be expected to alter the nutritional composition of the crop. The results of compositional analyses and livestock feeding studies demonstrated nutritional equivalence of maize grain from MON810 plants with maize grain from non-GM (Donkin et al., 2003; Taylor et al., 2003) . A review paper that examined historical data covering more than 15 years of livestock having been fed GE crops without evidence of harm and without noted differences in growth demonstrates the nutritional quality of and the lack of harmful substances (Van Eenennaam and Young, 2014) .
In addition to composition testing and livestock feeding trials, subchronic rodent feeding studies have been conducted with whole grains and edible fractions many from individual GE crops. These studies were conducted by incorporating the grain or processed food/feed fraction from a GE crop into a grain-based diet as a substitute for the non-GE fraction that would otherwise have been used in the formulation of the diets as the "experimental" group. In the case of GE maize, the concentration of grain was often in the range of 30%-40% of the diet. For soybeans, the primary processed fraction was soybean meal at a concentration of approximately 20%, though the final diets usually incorporated smaller proportions of soybean oil and hulls from the same GE crops. The control diets in these studies were produced by incorporation of the same concentrations of whole grains or processed fractions from near isogenic crops grown in field trials conducted specifically for the purpose of feeding trials. Additionally, many of these subchronic feeding studies included the same corresponding ingredients from commercially available, unrelated nonGE crops that were considered "reference" lines as was described previously to account for intrastudy variability of the variables that were measured (discussed below).
These studies represent a hybrid of nutritional performance studies as conducted with livestock animals and toxicology studies with laboratory rodents. The design of the studies is similar to nutritional comparison studies between two groups (control v. experimental), as is typical for livestock feeding studies. However, the data produced from these studies was consistent with subchronic rodent toxicology studies with regard to in-life and postmortem variables and pathology analysis. Where these studies differ from bona fide toxicology studies is that they normally did not evaluate multiple doses of the test substance, so quantitative risk assessment variables, such as the no-observed-adverse-effect level, were not identified. Rather, they were conducted to determine whether the food fraction from the particular GE crop was "as safe as" that of the corresponding fraction from a non-GE comparator using standard toxicology response variables.
Virtually all published subchronic studies with food or feed fractions from GE crops displayed at least a few statistical differences between the control and experimental groups. This was expected since so many variables were compared between two primary groups (control vs experimental) and because of background variability of the clinical parameters within animals in the individual treatment groups. This is the reason these studies included reference groups as noted above. As discussed previously in the section about compositional analysis, statistical differences are not automatically biologically relevant. Data from the reference groups were particularly helpful in understanding the within study distribution of individual variables to determine whether the primary statistical comparison was of biological relevance. In some cases, data from historical control groups also was helpful.
Numerous subchronic feeding studies have been reported for many GE crops, including corn (Appenzeller et al., 2009a,b; Delaney et al., 2013; Hammond et al., 2004 Hammond et al., , 2006 He et al., 2008 He et al., , 2009 Healy et al., 2008; Liu et al., 2012; MacKenzie et al., 2007; Malley et al., 2007; Zeljenkova et al., 2014; Zhu et al., 2013) , soy (Appenzeller et al., 2008; Delaney et al., 2008a; Hammond et al., 1996; Qi et al., 2012; Wang et al., 2016) , canola (Dryzga et al., 2007) , and sweet pepper and tomato (Chen et al., 2003) . To date, none of these studies has demonstrated evidence of adverse effects.
In addition to these subchronic studies, other types of toxicology studies have been conducted with whole grains and feed fractions from GE crops. These include reproductive toxicology studies (Snell et al., 2012; Wang et al., 2016; Zhou et al., 2012 Zhou et al., , 2014 and studies a year or greater in length (Sakamoto et al., 2007 (Sakamoto et al., , 2008 Zeljenkova et al., 2016; Zhang et al., 2014) . As with the subchronic studies cited earlier, none of these studies, when conducted properly, has identified any evidence of adverse effects.
The toxicology studies that have been conducted with food and feed fractions support the safety of the GE crops that were tested and demonstrate that the technology used to produce them is not inherently hazardous. In addition, these studies support the evidence from composition testing as predictive of the outcome of the toxicology studies. In particular, when substantial equivalence was demonstrable by composition testing, it would be expected that no adverse effects would occur if the same substances were subjected to toxicology studies. This has now been demonstrated many times with many GE crops, leading some to question whether subchronic rodent studies should continue to be conducted on a default basis (Bartholomaeus et al., 2013) .
ADDRESSING COMMON CONCERNS RELATED TO FOOD PRODUCED FROM GE CROPS
The primary concern of GE food crops is whether the newly expressed protein(s) represent new risks of food allergy or toxicity. Additional questions arise regarding potential increases in endogenous allergens, toxins, or antinutrients in the crop due to insertion of the new genetic material into the host genome. It is important to recognize that the process of genetic engineering does not, in itself, create new types of risks. Hazards are present in nature, and some are associated with conventional food crops as well (eg, solanine, a glycoalkaloid with limited toxicity in potatoes and tomatoes). We have outlined concerns and scientific information addressing these issues.
Do the Introduced Genes (Transgenes) Represent a Potential Risk?
DNA is a polymer of four different nucleotides (adenine, cytosine, guanine, and thymine) arranged in specific linear sequences that represent coding regions that are transcribed into RNA, which is translated into proteins, regulatory sequences that are involved in controlling gene expression or spacer sequences. Humans consume between 0.1 and 1 g of DNA in their diet each day through food from vegetables and animal sources; therefore, ingestion of DNA does not pose a risk (Palka-Santini et al., 2003) . Decades of research indicate that dietary DNA has no direct toxicity as it is extensively hydrolyzed during digestion (Einspanier et al., 2004; Jennings et al., 2003; Walsh et al., 2012) . According to the U.S. Food and Drug Administration (U.S. FDA) policy on foods derived from new plant varieties (U.S. FDA, 1992) , nucleic acids (both DNA and RNA) are present in all cells of every organism, including every plant and animal used for food by humans or animals. Therefore, nucleic acids do not raise a safety concern as a component of food. In U.S. regulatory terms, therefore, nucleic acids are presumed to be generally recognized as safe.
Some have speculated that DNA might be absorbed during digestion and incorporated into vertebrate consumers, however, studies have demonstrated the probability of transferring any transgene (or endogenous plant DNA) from a plant to either microbes or vertebrate consumers is close to zero (Nielsen et al., 2000; Nordgå rd et al., 2007; Rizzi et al., 2012; Sharma et al., 2006) . There has been no published evidence or other verifiable reports demonstrating that the consumed transgene has become part of the consumer's genome.
Does the Protein Expressed From the Transgene Present a Toxicological Risk?
The safety of the proteins expressed from newly inserted DNA is considered on a case-by-case basis using a weight-of-evidence (WOE) approach. The WOE approach involves the following considerations:
1. Whether the source of the gene encoding the protein has a history of safe use (human exposure). 2. Whether the amino acid sequence of the expressed protein bears significant identity to that of known toxins, as revealed by bioinformatics analysis. 3. Whether the protein is stable/digestible in the simulated gastric fluid in vitro (Ofori-Anti et al., 2008; Thomas et al., 2004) . Some also suggest testing stability in simulated intestinal fluid (SIF) with pancreatin or a combination of trypsin and chymotrypsin as the primary proteases. However, the predictive value of SIF for toxicity has not been demonstrated (Delaney et al., 2008b; Lin et al., 2013) . 4. Whether the mode of action of the protein suggests any possibility of toxicity, such as the generation of potentially toxic products from the enzymatic action of the protein.
The potential dietary exposure level of the protein or any metabolite if there is any potential hazard identified.
If one or more of these components is unclear during the evaluation of an individual protein, then additional tests (eg, animal studies) might be required. However, if no evidence of hazard is identified for the individual components, then additional animal toxicity studies are unlikely to contribute further to the safety assessment for that protein (Delaney et al., 2008b) . Nevertheless, some regulatory agencies require either an acute toxicity test in rodents or a repeat dose study be conducted with proteins newly expressed in GE crops (Mendelsohn et al., 2003) . Experience shows that the WOE approach noted above has served the safety assessment process well during the last 20 years.
Can the Food From the GE Crop be Allergenic?
One of the major concerns regarding the new protein(s) expressed in a GE crop is whether the new protein is an allergen that could cause immediate reactions in those with existing allergies. Allergy research has identified many of the likely food, airway, and contact allergenic proteins over the past 20 years. The primary risks of food allergy are from immediate reactions that occur following sensitization or the development of antigen-specific IgE antibodies to abundant proteins in commonly allergic foods. The IgE becomes bound by high-affinity FceRI receptors on mast cells and basophils. For those with existing allergies, the primary risk is from exposure to the allergen or to a structurally similar (ie, cross-reactive) protein that would be bound by the same IgE antibodies in the individual, causing an immediate allergic reaction. Questions addressed during the WOE evaluation of potential allergenicity of foods from GE crops are as follows:
1. Does the newly expressed food protein from a GE organism have the potential to elicit allergic reactions in individuals who are already sensitized to the same or a cross-reactive protein?
2. Is the newly expressed food protein in the GE organisms likely to induce de novo sensitization and become an allergen? 3. Will transgenic techniques alter the level of expression of existing (endogenous) allergens in the host crop plant if the host is a common source of food allergy (eg, peanut, tree nuts, and, arguably, soybeans or wheat)?
The first systematic approach to assess the potential risk of allergenicity to food proteins was described by the U.S. FDA ( The Codex guidelines provide a framework for evaluating risks of foods derived from modern biotechnology following specific steps to characterize the source of the transferred gene, expected gene products (proteins vs RNAi), and characteristics of gene products, genetic insert, and overall composition, including species specific nutrients, toxicants, and anti-nutrients. If the gene donor was wheat or a near-wheat relative, it is important to consider potential elicitation of celiac disease. Bioinformatic analysis of the protein sequence is used to compare the protein to known allergens. The stability of the protein also is tested in a fixed pepsin digestion assay.
Determinations of sequence and structural similarity. The sequence of the new protein encoded by the introduced transgene is compared to those of known allergens using well-curated allergen databases, such as AllergenOnline.org, which is updated every year (Goodman et al., 2016) . According to Codex guidelines, if the sequence identity matches an allergen above a relatively conservative threshold (>35% identity over a segment of 80 or more amino acids between a newly expressed protein and a known allergenic protein), then there may be a potential for cross-reactivity between IgE antibodies specific for the allergen and the newly expressed protein. With a significant amino acid sequence identity match, there is an expectation that serum IgE binding will be tested using samples from donors allergic to the source of the matched allergen and especially those with IgE binding to the matched allergen. In cases where in vitro IgE binding results appear positive, additional tests may be performed to evaluate the potential biological relevance of binding using either basophil activating capacity or in vivo reactivity (eg, skin prick tests). It should be recognized that few proteins (eg, 2S albumins and lipid transfer proteins) and food sources (eg, peanut, tree nuts, crustacean shellfish, fish, cow's milk, chicken eggs, and possibly wheat and soybeans), act as major allergenic sources that cause life-threatening reactions (Fernandez-Rivas, 2015; Hoffmann-Sommergruber et al., 2015; Sicherer and Sampson, 2014) . Many other allergens (eg, profilin, cyclophilin, and PR-10 proteins) or sources of allergy (eg, strawberries, carrots, and potatoes) represent minor risks and are often due to IgE cross-reactivity to similar proteins (Sicherer, 2001 ), although some cross-reactive proteins (eg, 2S albumins and vicilins) are potent allergens (Sirvent et al., 2014) . The allergenicity risk evaluation does not (yet) differentiate moderate-sequence identity matches to commonly potent allergens from those that only cause mild or no-reactions, which is something for further study.
Assessment of proteolytic stability. There exists a good, but not absolute, correlation between the resistance of proteins to proteolytic digestion and their allergenic potential. The theory is that relative resistance to digestion will facilitate induction of allergic responses provided the protein possesses allergenic properties (Astwood et al., 1996; Bannon et al., 2003; Ofori-Anti et al., 2008; Thomas et al., 2004) .
One approach, therefore, is to characterize the susceptibility of the newly expressed protein to in vitro degradation by pepsin in simulated gastric fluid. However, this approach alone may not be sufficient to identify proteins that are more likely to present a risk of food allergy if there is IgE binding. This is because the relative abundance of the protein in foods will be an important determinant of the overall risk for consumers if the protein represents a hazard. However, there is evidence that some rapidly digested proteins can also present some risk of food allergy, at least some mild reactions (Yagami et al., 2000) .
It is recognized, however, that most highly stable and abundant food proteins in commonly consumed food sources, such as lectins in common beans, do not cause food allergy (Goodman and Tetteh, 2011; Ofori-Anti et al., 2008) .
Although testing strategies for allergens are still evolving and no single test is fully predictive of human responses, it is important to evaluate and rank the risks and the uncertainties of risk before going further with recommendations for new tests .
Examples that demonstrate how the WOE has been used in regulatory decision-making on evaluation of potential allergenicity. StarLink corn was genetically engineered to express the Bt protein Cry9C to provide resistance to specific insects. Because the Cry9C protein was not rapidly digested in pepsin, the U.S. Environmental Protection Agency (U.S. EPA) approved the use of StarLink corn for animal feed, but not in human food. There was no other indication that Cry9C might be an allergen. The source was not allergenic, the sequence did not align with any allergen, and the protein was low in abundance. Controversy began when traces of Cry9C DNA from StarLink corn was detected in taco shells. News stories triggered claims of allergic reactions to cornproducts by 120 consumers in a 2-week period. Subsequent investigation by the Centers for Disease Control (CDC) did not substantiate those allergenicity claims (Raybourne et al., 2003; Sutton et al., 2003) . However, StarLink corn had to be withdrawn from the market with specific added testing to ensure the product was not in food. No consumers became ill due to consumption of the product. It took nearly 7 years to clear all residues from seed and feed products.
A methionine-rich 2 S albumin gene from Brazil nut was introduced into soybean to enhance animal feed quality. At the time, allergy to Brazil nuts was known, although uncommon, but the allergenic protein had not been identified. A study performed at the University of Nebraska-Lincoln demonstrated that serum from people allergic to Brazil nuts bound to the new soybean protein. Furthermore, those individuals developed positive skin prick test reactions to Brazil nut and to extracts of the GE soybean extract, but not to nonGE soybeans, demonstrating the protein, now known as Ber e 1, is an allergen (Nordlee et al., 1996) . Therefore, further development of the GE soybean variety was halted, and it was never commercialized.
Potential changes in the expression of endogenous allergens. Concerns have been raised that the insertion of the DNA in a commonly allergenic crop might lead to increased expression of endogenous allergens. To test this, serum from soybean allergic subjects have been used to test for increases in IgE binding to proteins in GE, near isogenic lines and other commercial non-GE varieties of soybeans. Approximately 0.1%-0.4% of young children may have allergies to soybeans, but few adults. The prevalence of allergy to most food crops is far too low to identify allergic subjects for testing. The results have not identified increases in IgE binding to soybean proteins (Burks and Fuchs, 1995; Goodman et al., 2013; Panda et al., 2013) .
Will Insertion of the Transgene Increase the Potential Hazard From Toxins or Pharmacologically Active Substances Present in the Host? Some have speculated that inserting DNA into the genome of the host plant may lead to unexpected changes in plant composition that might adversely impact human or animal health. Yet, compositional analysis and animal feeding experiences have not found evidence of changes in key metabolites in GE plants that would cause nutritional deficiencies or adverse reactions in consumers during the 20-plus years from the first approved GE crops (Van Eenennaam and Young, 2014 ). Yet, it is clear that unexpected and potentially undesirable changes in the genome of conventionally bred plants can occur in all plants (eg, Kuiper et al., 2002; Ladics et al., 2015) . Developers of both conventionally bred and GE crops select only those plant events that grow and produce normally, thereby discarding >95% of plants with off-types that do not have the desired agronomic and/or phenotypic characteristics. This agronomic selection process removes most of the undesirable or unintended impacts of transformation. Tests of the composition of edible parts of GE plants are compared to the composition of near isogenic and commercial varieties to evaluate the nutritional value of the plants. Although some have speculated that biotechnology could result in increases in concentrations of minor ingredients or possibly the production of entirely new ingredients that could produce adverse effects upon consumption, there is no evidence that this has ever occurred. This also is supported by comparative feeding studies conducted with agriculturally important animal species, including beef cattle, catfish, chickens, dairy cows, and pigs (Van Eenennaam and Young, 2014) .
Some scientists affiliated with the European Food Safety Authority (EFSA) (Pielaat et al., 2013; Waigmann et al., 2012) and the U.S. National Academy of Sciences (2016) have suggested that 'omics (eg, genomics, metabolomics, proteomics, and transcriptomics) might provide useful information to determine whether insertion of the gene into an organism has altered an important ingredient. Ricroch (2013) reported the analysis of data from several high-throughput 'omics comparisons between GE and nonGE crop lines. The analysis revealed that the impact of environmental factors, as well as conventional plant breeding, on plant gene expression and composition is much more pronounced than changes attributable to the genetic engineering process. Thus, 'omics profiling studies are not used in the regulatory or safety testing of GE crops nor are they currently providing data useful for hazard identification or risk assessment though it is a possibility that these methodologies could be of use for these purposes at some point in the future.
Will the Insertion of the Transgene That Does Not Code for a Protein, But Suppresses the Expression of an Endogenous Gene, Pose a Potential New Hazard to the Consumer? RNAi is a natural phenomenon operating in diverse eukaryotes (Cerutti and Casas-Mollano, 2006) . In plants, RNAi regulates many physiological processes, including metabolism and pathogenesis (Younis et al., 2014) . Because RNAi has the potential for off-target effects in plants (eg, silencing other nontarget genes simply because of the sequence similarity to the target genes), RNAi-derived GE crops are subject to the same rigorous safety review process as those containing transgenes that express new proteins (Carvalho et al., 2015; Petrick et al., 2013) . Several RNAiderived food crops have been reviewed and approved by at least one international regulatory agency. These events encompass a wide variety of plant species from corn to potato and papaya and include a range of traits, such as virus resistance and oil composition modification (Frizzi and Huang, 2010; Sherman et al., 2015) .
Some have questioned whether the consumption of foods from RNAi-derived GE plants could result in uptake of these small RNA by the mammalian gut and transfer into systemic circulation with the potential for impacting health (Zhang et al., 2012) . Studies by Dickinson et al. (2013) , Snow et al. (2013) , and Witwer et al. (2013) demonstrated that mammals have biological barriers to absorption of ingested miRNA. Additional proof of safety was recently reported from studies in mice (Petrick et al., , 2016 . It has further been speculated that there may be sensitive populations of persons with compromised (ie, leaky) gut functions that would allow for the absorption of intact RNAi though there is little, if any, evidence to support this idea. Further, even if this concept was correct there is no reason to believe that the RNAi from a GE plant would be any more likely to be absorbed than from any other dietary source since RNAi are present in virtually all foods derived from living organisms. Therefore, the consumption of GE plants expressing noncoding miRNA is not expected to adversely impact the health of consumers.
Does the Possible Transfer of ARM Genes From the Ingested Food From a GE Crop to Gut Microbes Present a Significant Human Hazard?
The development of antibiotic resistance among pathogenic bacteria has remained a hotly debated issue since the beginning of the development of GE crops. However, no contribution to antibiotic resistance in gut or environmental bacteria arising from the use of ARMs in foods from GE crops has been documented. The nptII gene (NPTII protein) marker that is the primary ARM allowed by most countries is resistant to kanamycin and neomycin-antibiotics that are rarely used to treat infectious diseases in humans (European Food Safety Authority, 2007; U.S. FDA, 2010) .
The probability for transfer of an ARM to intestinal or environmental microbes is extremely low for several reasons, including the efficient destruction of the resistance gene in the human gut and the low intrinsic rate of plant-microbe gene transfer (Goldstein et al., 2005; The Royal Society, 1998) . There have been rigorous trials attempting to measure the transfer of the nptII gene from plant DNA into a soil microbe that readily accepts DNA and in the gastrointestinal tract of rats in the aerobic microbiota, but all have failed to detect successful transfer and expression (Nielsen et al., 2000; Nordgard et al., 2007) . Despite the lack of evidence on the possible transfer of ARM genes from the ingested GE food to gut microbiota, the use of ARM has steadily declined over the course of the development of GE crops during the last 20 years. However, many original events are still cultivated widely and some new ones are being developed using NPTII as a selectable marker.
Will Genetic Transformation Adversely Affect the Nutritional Value of the Host?
The GE crop development process, including agronomic selection of the transformants, and compositional analyses ensure that nutritional changes are highly unlikely in the host plant. As much as 90% of the biomass produced by GE crops is consumed by livestock animals and not humans. Since the commercialization of GE crops, more than 100 billion animals have consumed them at high dietary inclusion rates with no evidence of adverse health or nutritional effects and no changes in the profile of nutritional products obtained from the livestock animals (Van Eenennaam and Young, 2014) .
CONCLUSION
Decades of testing food and feed products from insect resistant, herbicide tolerant and stacked traits of previously approved single traits, and other types of GE crops in laboratory and livestock animals have shown that the technology used to produce them is not inherently hazardous. No adverse effects have been observed to date. Based on the consistency of these observations from so many different GE crops, it is uncertain whether animal feeding studies should be conducted as a default regulatory requirement in the future (Devos et al., 2016; Hartnell et al., 2007; Van Eenennaam and Young, 2014) .
Future safety assessment strategies need to take into consideration the nature of the engineered proteins, such as transcription factors, or integral membrane proteins. Because transcription factors can alter the expression of many target genes, GE crops in which such proteins have been engineered may require a more complex evaluation compared to a gene encoding a single protein. Integral membrane proteins are difficult to purify in natural form or the quantities necessary to do laboratory pepsin digestion studies or animal studies. Thus, such proteins may require alternative in vitro methods to establish their safety (Bushey et al., 2014; Hurley et al., 2016) .
Currently, it is not obvious how the safety assessment of the next generation of GE crops developed using genome editing tools will be conducted because such GE crops are not expected to be inherently hazardous, and unless a new coding region (gene) was transferred into the plant using this technology, there are no obvious risks to evaluate. Nevertheless, because of their "newness," products developed using these technologies are likely to be subjected to some type of safety assessment, although the safety assessment paradigm may differ from those used previously (Fischhoff and Cline, 2009; Ricroch and HenardDamave, 2016) .
Finally, though the benefits of biotechnology to the environment and to the farmers who plant crops produced from it have been well-documented, there remains a significant proportion of the population that is skeptical about their safety. In some cases, this fear has led to the failure to approve products, such as Golden Rice 2, in places where their benefits could be both rapid and significant. In the future, individuals developing GE products should strongly consider more aggressive outreach to demonstrate the safety and benefits of their products. This outreach will likely need to go beyond the traditional audience of regulatory and scientific authorities and speak directly to consumers.
